重视中国人小眼球或无眼球眼眶发育的规范化治疗

Give attention to standardized management of orbital development in Chinese with microphthalmosor anophthalmos

先天性及获得性小眼球、无眼球为临床常见病例，在患者发育期，如不及时合理地进行眼眶发育的干预治疗，将导致颜面畸形，从而严重损毁了患者的面部容貌，是儿童期因颜面部畸形就医的主要原因。目前国内对于小眼球或无眼球眼眶发育的干预方法很不规范，相当多的患者丧失了最佳整复时机。本文针对国内现有条件下，对小眼球、无眼球眼眶发育的合理干预治疗进行阐述，指出1～3岁以不断增大的定时更换义眼为主要方法，而在3～5岁后可采用眶内植入物。并指出对于此类患儿应进行合理的定时性疗效评估，此为指导治疗的关键。

Congenital and acquired microphthalmos or anophthalmos are common ocular disorders that cause facial disfigurement in children. It is important to have timely and reasonable treatment to promote orbital growth. At present status, many patients miss the optimum opportunity for orbital reconstruction because of non-standardized management in China. The correct management for promoting orbital growth in microphthalmos or anophthalmos is thus elaborated. Conformers with progressively increasing size can be used in children at 1 - 3 years of age ; while orbital implants could be used after 3 - 5 years of age. Rational and regular evaluation of the efficacy is critical for guiding the treatment process.